Subscriber ContentRead Preview
Led by cable mogul John Malone and CEO Greg Maffei, the nine stocks under the Liberty Media umbrella have delivered, in the aggregate, an annualized 13% over the past decade, compared with 7.5% for Bufftet’s Berkshire Hathaway and 7.7% for the S&P 500.
Subscriber Content Read Preview
Four market pros share their outlook for Asia and their best investment picks. Bullish on India.
Subscriber Content Read Preview
Broadcom chips are doing more to power the iPhone, and could play an even bigger role with next year’s release of iPhone 8.
Subscriber Content Read Preview
The movie-theater operator is launching new initiatives that could boost ticket sales and earnings.
Subscriber Content Read Preview
Michael Beall has posted strong returns by investing in value stocks with the power to raise dividends.
Subscriber Content Read Preview
A movement aims to undo past “Progressive” policies with a general reconsideration of the Constitution.
Subscriber Content Read Preview
We celebrate the second anniversary of Barron’s Asia’s launch with a comprehensive investment roundtable surveying local markets.
Subscriber Content Read Preview
The market finished an up-and-down week on a positive note, helped by a strong showing from energy stocks.
Subscriber Content Read Preview
Off Wall Street Research analyst Mark Roberts has flagged many stocks not worth buying.
Subscriber Content Read Preview
If CBS and Viacom strike a deal, CBS chief Les Moonves will have an outsize say over the terms.
Subscriber Content Read Preview
The German utility has struggled with weak energy pricing and a bill to decommission nuclear plants. Its answer: Break the company in two.
Subscriber Content Read Preview
State-owned Bank Mandiri is a designated gateway for funds returning to Indonesia. But the benefit may be small and its problems look large.
Subscriber Content Read Preview
Through the first three quarters, Latin stocks have soared while Greek and Chinese shares have fallen.
Subscriber Content Read Preview
Investors should look at business development companies, publicly traded firms that buy loans.
Subscriber Content Read Preview
Need to protect yourself against, say, a Trump victory? Take out an insurance policy of options.
Subscriber Content Read Preview
A surge in U.S. demand has produced an oversupply. Prices are likely to fall further.
Subscriber Content Read Preview
By roiling the markets, it and other European financial institutions could jack rates, hurting the global economy.
Subscriber Content Read Preview
The group has become riskier, but some of its members, including Johnson & Johnson, Amgen, Medtronic, Allergan,and Lilly, are still worth a look.
Subscriber Content Read Preview
As dominant as they are today, Alphabet and Facebook could lose out to new ways of delivering advertising.
Subscriber Content Read Preview
Managers’ drive to gather assets means successors to closed funds will keep popping up even if they hurt returns.
Subscriber Content Read Preview
It’s a good time for investors to consider biotech ETFs that hold smaller drugmakers.
Subscriber Content Read Preview
Most of these stocks remain quite cheap, but investors need to approach them carefully. The problem: growth challenges.
Subscriber Content Read Preview
Andrew Bacevich writes a riveting history of U.S. military misadventures in Afghanistan, Iraq, and elsewhere. Also, a meditation on mortality’s benefits.
Subscriber Content Read Preview
Both Hillary Clinton and Donald Trump misstated realities in the first of their televised face-offs.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
CBS Chief Les Moonves likely could find huge synergies from combining with Viacom. With or without a deal, CBS shares could double by 2020.
Families with over $5 million in investible assets surpass one million for first time
Enjoying your health and wealth in retirement takes more work than you might think. Our pros look beyond the numbers. What about the kids?
Stocks could tread water for the rest of the year—or even fall. Wall Street’s top strategists also predict only modest gains in 2017.
Barron’s picks have hefty yields and nice prices. Why JPMorgan Chase, Verizon, Target, and MetLife make the grade.
The presidential candidates focus on the trade deficit in goods when they should consider the surplus in services and other benefits of free trade.
Alternative-energy and hospital stocks could prosper under a Clinton administration, while energy and financial shares could take a big hit.
Our savvy market experts reveal which funds and individual securities maximize income and minimize risk.
The Morgan Stanley macroeconomist sees more woes ahead for China and Russia. The U.S., India, and Germany will prosper.
American Express, Coca-Cola and others team up to try to cut high drug prices. Shares of Express Scripts, CVS, UnitedHealth are at risk.
Liberty Media’s nine stocks have delivered, in the aggregate, an annualized 13% over the past decade.
IHS Markit is out with its fourth quarter dividend preview. See which companies may make big hikes.
Subscriber Content Read Preview
CalAtlantic and KB Home have the most exposure to the top 10 new-construction housing markets in the U.S.
Subscriber Content Read Preview
A combination of double-digit top-line growth and modest incremental margin expansion will bolster the firm.
Subscriber Content Read Preview
TD Ameritrade may be the most logical buyer but there could be regulatory complications.